James Mackay is tending to ‘unfinished business’ with new gout biotech and $205M fundraise September 30, 2025
Avenzo collects another $60M for two small molecules and two ADCs licensed from China September 22, 2025
Solu Developing a Powerful New Therapeutic Modality that Unlocks Cell Surface Targets September 12, 2025
